[THE DEVELOPMENT OF STROPHANTHIN TREATMENT SINCE ALBERT FRAENKEL]. 1964

K BLUMBERGER

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006664 History Record and study of past events. Aspects, Historical,Historical Aspects,Aspect, Historical,Historical Aspect,Histories
D013328 Strophanthins A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides. Strophanthin

Related Publications

K BLUMBERGER
March 1957, Munchener medizinische Wochenschrift (1950),
K BLUMBERGER
January 1964, Medico; Europa Ausg,
K BLUMBERGER
January 1992, Zeitschrift fur arztliche Fortbildung,
K BLUMBERGER
May 1978, ZFA. Zeitschrift fur Allgemeinmedizin,
K BLUMBERGER
September 1990, Casopis lekaru ceskych,
K BLUMBERGER
September 1972, Vnitrni lekarstvi,
K BLUMBERGER
August 1972, Ceskoslovenske zdravotnictvi,
Copied contents to your clipboard!